Engineers and cancer researchers have harnessed the power of machine learning technology to predict immune-boosting proteins.
Machine learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.
If validated in clinical trials, the technology could help scientists overcome a major hurdle to developing personalised immunotherapies and vaccines.
In a new study, investigators from Johns Hopkins Biomedical Engineering, the Johns Hopkins Institute for Computational Medicine, the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy show that their deep learning method, called BigMHC, can identify protein fragments on cancer cells that elicit a tumour cell-killing immune response, an essential step in understanding response to immunotherapy and in developing personalised cancer therapies… Continue reading.
Rachel Karchin, PhD, is a professor of biomedical engineering, oncology, and computer science, with joint appointments at the Whiting School of Engineering and School of Medicine at Johns Hopkins University in Baltimore. She is a core member of the Institute for Computational Medicine.
A computational biologist, Dr. Karchin develops algorithms and software to analyze genomic data and interpret its impact on human disease. Her most recent work has focused on cancer and the effects of germline and somatic alterations and their contributions to progression models of tumor evolution. She led the computational efforts to identify driver mutations for the Johns Hopkins Sidney Kimmel Cancer Center’s pioneering cancer sequencing projects, and she co-led The Cancer Genome Atlas (TCGA) PanCancer Atlas Essential Genes and Drivers Analysis Working Group.
Cancer Network asked Dr. Karchin about the contemporary search for cancer-driving gene mutations… Continue reading.
WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Rachel Karchin, Ph.D., Associate Professor The William R. Brody Faculty Scholar, Biomedical Engineering / Oncology / Institute of Computational Medicine, Johns Hopkins University, to its College of Fellows. Dr. Karchin was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to translational bioinformatics and computational molecular precision medicine..